Lessons to be learned from animal studies on hormones and the breast

Maturitas

Volumn 49, Issue 1, 2004, Pages 79-89

  Clarkson, Thomas B ^a   Appt, Sue E ^a   Wood, Charles E ^a   Cline, J Mark ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Hormones; Menopause; Monkeys; Rodents

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CELL PROLIFERATION; CONFERENCE PAPER; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; HORMONAL THERAPY; HORMONE ACTION; METHODOLOGY; MONKEY; MONOTHERAPY; NONHUMAN; PRIMATE; RISK ASSESSMENT; RODENT;

ANIMALS; BREAST; ESTROGEN REPLACEMENT THERAPY; FEMALE; GONADAL STEROID HORMONES; HAPLORHINI; MENOPAUSE; MODELS, ANIMAL; RANDOMIZED CONTROLLED TRIALS; RATS;

ANIMALIA; EQUIDAE; PRIMATES; RODENTIA;

EID: 4444382094     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.06.012     Document Type: Conference Paper

References (52)

1. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333
2. Weiss L.K., Burkman R.T., Cushing-Haugen K.L., et al. Hormone replacement therapy regimens and breast cancer risk(1). Obstet. Gynecol. 100:2002;1148-1158
3. Chlebowski R.T., Hendrix S.L., Langer R.D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 289:2003;3243-3253
4. Schairer C., Lubin J., Troisi R., et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 283:2000;485-491
5. Ross R.K., Paganini-Hill A., Wan P.C., Pike M.C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 92:2000;328-332
6. Kuller L.H. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 92:2000;1100-1101
7. Moyer D.L., Felix J.C. The effects of progesterone and progestins on endometrial proliferation. Contraception. 57:1998;399-403
8. Felix J.C., Farahmand S. Endometrial glandular proliferation and estrogen receptor content during the normal menstrual cycle. Contraception. 55:1997;19-22
9. Soderqvist G., Isaksson E., von Schoultz B., et al. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am. J. Obstet. Gynecol. 176:1997;123-128
10. Longacre T.A., Bartow S.A. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am. J. Surg. Pathol. 10:1986;382-393
11. Masters J.R., Drife J.O., Scarisbrick J.J. Cyclic variation of DNA synthesis in human breast epithelium. J. Natl. Cancer Inst. 58:1977;1263-1265
12. Meyer J.S. Cell proliferation in normal human breast ducts, fibroadenomas, age, and oral contraceptive hormones. Hum. Pathol. 8:1977;67-81
13. Anderson T.J., Ferguson D.J., Raab G.M. Cell turnover in the resting human breast: influence of parity, contraceptive pill, age and laterality. Br. J. Cancer. 46:1982;376-382
14. Potten C.S., Watson R.J., Williams G.T., et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br. J. Cancer. 58:1988;163-170
15. Fata J.E., Chaudhary V., Khokha R. Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle. Biol. Reprod. 65:2001;680-688
16. Raafat A.M., Hofseth L.J., Haslam S.Z. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model. Am. J. Obstet. Gynecol. 184:2001;340-349
17. Wang S., Counterman L.J., Haslam S.Z. Progesterone action in normal mouse mammary gland. Endocrinology. 127:1990;2183-2189
18. Said T.K., Conneely O.M., Medina D., O'Malley B.W., Lydon J.P. Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology. 138:1997;3933-3939
19. Haslam S.Z. Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology. 122:1988;464-470
20. Lydon J.P., DeMayo F.J., Funk C.R., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:1995;2266-2278
21. Lydon J.P., Ge G., Kittrell F.S., Medina D., O'Malley B.W. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 59:1999;4276-4284
22. Sakamoto S., Mori T., Shinoda H., Sassa S., Koyama T. Effects of conjugated estrogens with or without medroxyprogesterone acetate on mammary carcinogenesis, uterine adenomyosis and femur in mice. Acta Anat. (Basel). 159:1997;204-208
23. Laidlaw I.J., Clarke R.B., Howell A., et al. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology. 136:1995;164-171
24. McManus M.J., Welsch C.W. The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer. 54:1984;1920-1927
25. Sakamoto S., Kudo H., Suzuki S., et al. Additional effects of medroxyprogesterone acetate on mammary tumors in oophorectomized, estrogenized, DMBA-treated rats. Anticancer Res. 17:1997;4583-4587
26. Ohi Y., Yoshida H. Influence of estrogen and progesterone on the induction of mammary carcinomas by 7,12-dimethylbenz(a)anthracene in ovariectomized rats. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 62:1992;365-370
27. Huggins C.G.L.B.F. Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Nature. 189:1961;204-207
28. Huggins C.Y.N. Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cure of breast cancer. Science. 137:1962;257-262
29. Hennighausen L., Robinson G.W. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12:1998;449-455
30. Nandi S., Guzman R.C., Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3650-3657
31. Yue W., Wang J.P., Hamilton C.J., Demers L.M., Santen R.J. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res. 58:1998;927-932
32. Labrie F., Belanger A., Simard J., Van L., Labrie C. DHEA and peripheral androgen and estrogen formation: intracinology. Ann. N. Y. Acad. Sci. 774:1995;16-28
33. Speert H. The normal and experimental development of the mammary gland of the rhesus monkey with some pathologic correlations. Contributions to embryology. Carnegie Inst. Washington. 32:1948;9-65
34. Mahoney C.J. A study of the menstrual cycle in Macaca irus with special reference to the detection of ovulation. J. Reprod. Fertil. 21:1970;153-163
35. Tsubura A., Hatano T., Hayama S., Morii S. Immunophenotypic difference of keratin expression in normal mammary glandular cells from five different species. Acta Anat. (Basel). 140:1991;287-293
36. Cline J.M., Soderqvist G., von Schoultz E., Skoog L., von Schoultz B. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am. J. Obstet. Gynecol. 174:1996;93-100
37. Cline J.M., Soderqvist G., von Schoultz E., Skoog L., von Schoultz B. Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques. Breast Cancer Res. Treat. 48:1998;221-229
38. Macpherson E.E., Montagna W. Proceedings: the mammary glands of rhesus monkeys. J. Invest. Dermatol. 63:1974;17-18
39. Uno H. Age-related pathology and biosenescent markers in captive rhesus macaques. Age. 20:1997;1-13
40. Cline J.M., Register T.C., Clarkson T.B. Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys. Menopause. 9:2002;422-429
41. Chetrite G., Kloosterboer H.J., Pasqualini J.R. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res. 17:1997;135-140
42. Chetrite G.S., Kloosterboer H.J., Philippe J.C., Pasqualini J.R. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines. Anticancer Res. 19:1999;269-275
43. Chetrite G.S., Kloosterboer H.J., Philippe J.C., Pasqualini J.R. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells. Anticancer Res. 19:1999;261-267
44. Purohit A., Malini B., Hooymans C., Newman S.P. Inhibition of oestrone sulphatase activity by tibolone and its metabolites. Horm. Metab. Res. 34:2002;1-6
45. van de Ven J., Donker G.H., Sprong M., Blankenstein M.A., Thijssen J.H. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells. J. Steroid Biochem. Mol. Biol. 81:2002;237-247
46. Dimitrakakis C., Zhou J., Wang J., et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause. 10:2003;292-298
47. Foth D., Cline J.M. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am. J. Clin. Nutr. 68:1998;1413S-1417S
48. Mills L.H., Lee A.J., Parlow A.F., Zhu B.T. Preferential growth stimulation of mammary glands over uterine endometrium in female rats by a naturally occurring estradiol-17beta-fatty acid ester. Cancer Res. 61:2001;5764-5770
49. Vihma V., Tiitinen A., Ylikorkala O., Tikkanen M.J. Quantitative determination of estradiol fatty acid esters in lipoprotein fractions in human blood. J. Clin. Endocrinol. Metab. 88:2003;2552-2555
50. Larner J.M., Shackleton C.H., Roitman E., Schwartz P.E., Hochberg R.B. Measurement of estradiol-17-fatty acid esters in human tissues. J. Clin. Endocrinol. Metab. 75:1992;195-200
51. Leszczynski D.E., Schafer R.M. Metabolic conversion of six steroid hormones by human plasma high-density lipoprotein. Biochim. Biophys. Acta. 1083:1991;18-28
52. Suparto I.H., Williams J.K., Cline J.M., Anthony M.S., Fox J.L. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys. Am. J. Obstet. Gynecol. 188:2003;1132-1140